经左心室心尖部活检诊断为体外膜肺氧合和左心室辅助装置支持后发生的播散性恶性肿瘤。
Disseminated malignancy after extracorporeal life support and left ventricular assist device, diagnosed by left ventricular apical core biopsy.
作者信息
Philipsen Tine E, Vermeulen Tom, Conraads Viviane M, Rodrigus Inez E
机构信息
Department of Cardiac Surgery, University Hospital Antwerp, Edegem, Belgium.
出版信息
Interact Cardiovasc Thorac Surg. 2013 Nov;17(5):875-7. doi: 10.1093/icvts/ivt334. Epub 2013 Jul 30.
Abstract
The left ventricular apical core biopsy performed during implantation of a left ventricular assist device (VAD) is a well-known diagnostic procedure in confirming cardiomyopathies leading to end-stage heart failure. We describe a patient in whom disseminated malignancy was revealed by means of the apical core biopsy after extracorporeal life support and left ventricular assist device implantation as a bridge to transplantation. This case emphasizes the importance of thorough oncological screening before VAD implantation and the possible consequences of circulating tumour cells in this device-assisted circulation.
摘要
在植入左心室辅助装置（VAD）期间进行的左心室心尖部核心活检是确诊导致终末期心力衰竭的心肌病的一种众所周知的诊断方法。我们描述了一名患者，在接受体外生命支持和植入左心室辅助装置作为移植过渡手段后，通过心尖部核心活检发现了播散性恶性肿瘤。该病例强调了在植入VAD前进行全面肿瘤筛查的重要性以及循环肿瘤细胞在这种装置辅助循环中可能产生的后果。
相似文献
1
Disseminated malignancy after extracorporeal life support and left ventricular assist device, diagnosed by left ventricular apical core biopsy.
Interact Cardiovasc Thorac Surg. 2013 Nov;17(5):875-7. doi: 10.1093/icvts/ivt334. Epub 2013 Jul 30.
2
Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
Cardiovasc Drugs Ther. 2018 Aug;32(4):373-379. doi: 10.1007/s10557-018-6796-8.
3
Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock.
Eur J Cardiothorac Surg. 2017 Mar 1;51(3):591-596. doi: 10.1093/ejcts/ezw349.
4
A Novel Extracorporeal Continuous-Flow Ventricular Assist System for Patients With Advanced Heart Failure - Initial Clinical Experience.
Circ J. 2020 Jun 25;84(7):1090-1096. doi: 10.1253/circj.CJ-19-1122. Epub 2020 May 28.
5
Outcomes of venopulmonary arterial extracorporeal life support as temporary right ventricular support after left ventricular assist implantation.
J Thorac Cardiovasc Surg. 2018 Dec;156(6):2143-2152. doi: 10.1016/j.jtcvs.2018.05.077. Epub 2018 Jun 5.
6
"The Trapped Ventricle": Importance of Left Ventricular Unloading in Resuscitated Patients on VA-ECMO.
JACC Cardiovasc Interv. 2019 Feb 25;12(4):e33-e34. doi: 10.1016/j.jcin.2018.12.009. Epub 2019 Jan 30.
7
Clinical experience with temporary right ventricular mechanical circulatory support.
J Thorac Cardiovasc Surg. 2018 Nov;156(5):1885-1891. doi: 10.1016/j.jtcvs.2018.04.094. Epub 2018 May 1.
8
Selective implantation of durable left ventricular assist devices as primary therapy for refractory cardiogenic shock.
J Thorac Cardiovasc Surg. 2018 Mar;155(3):1059-1068. doi: 10.1016/j.jtcvs.2017.10.136. Epub 2017 Nov 21.
9
Ambulatory central VA-ECMO with biventricular decompression for acute cardiogenic shock.
Catheter Cardiovasc Interv. 2018 Nov 1;92(5):1002-1004. doi: 10.1002/ccd.27428. Epub 2017 Dec 4.
10
Extracorporeal Membrane Oxygenation as a Bridge to Durable Mechanical Circulatory Support: An Analysis of the STS-INTERMACS Database.
Circ Heart Fail. 2020 Mar;13(3):e006387. doi: 10.1161/CIRCHEARTFAILURE.119.006387. Epub 2020 Mar 13.
引用本文的文献
1
Embolized Hydrophilic Coating Polymers Found in Left Ventricular Assist Device Apical Core Specimen.
JACC Case Rep. 2022 Jul 6;4(13):819-821. doi: 10.1016/j.jaccas.2022.03.035.
本文引用的文献
1
Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical "core" excised for insertion of a left ventricular assist device for severe chronic heart failure.
Am J Cardiol. 2009 Jan 1;103(1):110-4. doi: 10.1016/j.amjcard.2008.08.053. Epub 2008 Oct 30.
2
Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature.
Am J Cardiol. 2008 Sep 1;102(5):643-5. doi: 10.1016/j.amjcard.2008.04.042. Epub 2008 Jul 10.
3
Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement.
Cardiovasc Pathol. 2009 Jul-Aug;18(4):217-22. doi: 10.1016/j.carpath.2008.06.007. Epub 2008 Aug 15.
4
Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma.
BMC Cancer. 2005 Oct 31;5:142. doi: 10.1186/1471-2407-5-142.
5
Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis.
Mod Pathol. 2005 Nov;18(11):1417-23. doi: 10.1038/modpathol.3800449.
6
Pathology in patients with ventricular assist devices: a study of 21 autopsies, 24 ventricular apical core biopsies and 24 explanted hearts.
Cardiovasc Pathol. 2005 Jan-Feb;14(1):19-23. doi: 10.1016/j.carpath.2004.10.002.
7
Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support.
J Heart Lung Transplant. 2004 Jan;23(1):36-42. doi: 10.1016/s1053-2498(03)00103-7.
8
Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk?
J Thorac Cardiovasc Surg. 2003 Aug;126(2):436-41. doi: 10.1016/s0022-5223(03)00056-4.
9
Urgent heart surgery for an atrial mass: metastatic hepatocellular carcinoma.
Ann Thorac Surg. 2001 Sep;72(3):931-3. doi: 10.1016/s0003-4975(00)02409-7.
Zotero 插件